SERUM BIOMARKER SIGNATURE IS PREDICTIVE OF THE RISK OF HEPATOCELLULAR CANCER IN PATIENTS WITH CIRRHOSIS

被引：0
|
作者：
El-Serag, Hashem B.
Kanwal, Fasiha
Ning, Jing
Powell, Hannah
Khaderi, Saira
Singal, Amit G.
Asrani, Sumeet K.
Marrero, Jorge A.
Amos, Christopher I.
Thrift, Aaron P.
Luster, Michelle
Alsarraj, Abeer
Olivares, Luis
Skapura, Darlene G.
Deng, Jenny
Salem, Emad
Najjar, Omar
Yu, Xian
Duong, Hao T.
Scheurer, Michael
Ballantyne, Christie M.
Kaochar, Salma
机构：
来源：
GASTROENTEROLOGY | 2024年 / 166卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1251
引用
收藏
页码：S295 / S295
页数：1
相关论文
共 50 条
  • [31] Risk for Hepatocellular Carcinoma in Patients With Alcoholic Cirrhosis
    Abegunde, Ayokunle T.
    ANNALS OF INTERNAL MEDICINE, 2012, 157 (09) : 677 - 677
  • [32] Predictive score for the development of hepatocellular carcinoma (HCC) in patients with cirrhosis
    Rodriguez, M
    Velazquez, RF
    Linares, A
    Navascues, CA
    Cabuenes, H
    Perez, R
    Sotorrio, NG
    Martinez, I
    Dieguez, LG
    Rodrigo, L
    HEPATOLOGY, 2000, 32 (04) : 617A - 617A
  • [33] Identification of a serum biomarker signature associated with metastatic prostate cancer
    Emruli, Venera Kuci
    Liljedahl, Leena
    Axelsson, Ulrika
    Richter, Corinna
    Theorin, Lisa
    Bjartell, Anders
    Lilja, Hans
    Donovan, Jenny
    Neal, David
    Hamdy, Freddie C.
    Borrebaeck, Carl A. K.
    PROTEOMICS CLINICAL APPLICATIONS, 2021, 15 (2-3)
  • [34] Serum mass profile signature as a biomarker of early lung cancer
    Widlak, Piotr
    Pietrowska, Monika
    Polanska, Joanna
    Marczyk, Michal
    Ros-Mazurczyk, Malgorzata
    Dziadziuszko, Rafal
    Jassem, Jacek
    Rzyman, Witold
    LUNG CANCER, 2016, 99 : 46 - 52
  • [35] Serum Midkine as a Prognostic Biomarker for Patients With Hepatocellular Carcinoma
    Hung, Yi-Ju
    Lin, Zoe H. Y.
    Cheng, Tsun-I
    Liang, Chung-Ting
    Kuo, Tse-Ming
    Kao, Kuo-Jang
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2011, 136 (04) : 594 - 603
  • [36] Is serum free RNA available as a predictive biomarker for the response to chemotherapy in patients with lung cancer
    Son, Choonhee
    Roh, Mee-Sook
    Um, Soo-Jung
    Kim, Kyu Sik
    CANCER RESEARCH, 2011, 71
  • [37] Baseline Serum Albumin Is a Predictive Biomarker for Patients With Advanced Pancreatic Cancer Treated With Bevacizumab
    Pant, Shubham
    Martin, Ludmila K.
    Geyer, Susan
    Wei, Lai
    Van Loon, Katherine
    Sommovilla, Nilli
    Zalupski, Mark
    Iyer, Renuka
    Fogelman, David
    Ko, Andrew H.
    Bekaii-Saab, Tanios
    CANCER, 2014, 120 (12) : 1780 - 1786
  • [38] Metabolomic Characterization of Hepatocellular Carcinoma in Patients with Liver Cirrhosis for Biomarker Discovery
    Di Poto, Cristina
    Ferrarini, Alessia
    Zhao, Yi
    Varghese, Rency S.
    Tu, Chao
    Zuo, Yiming
    Wang, Minkun
    Ranjbar, Mohammad R. Nezami
    Luo, Yue
    Zhang, Chi
    Desai, Chirag S.
    Shetty, Kirti
    Tadesse, Mahlet G.
    Ressom, Habtom W.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2017, 26 (05) : 675 - 683
  • [39] Serum miRNAs as predictive and preventive biomarker for pre-clinical hepatocellular carcinoma
    Li, Liang
    Chen, Jianguo
    Chen, Xin
    Tang, Jing
    Guo, Huan
    Wang, Xiaofeng
    Qian, Ji
    Luo, Guijuan
    He, Fangping
    Lu, Xiaomei
    Ding, Yibo
    Yang, Yingchen
    Huang, Wentao
    Hou, Guojun
    Lin, Ximeng
    Ouyang, Qin
    Li, Hengyu
    Wang, Ruoyu
    Jiang, Feng
    Pu, Rui
    Lu, Jianhua
    Jin, Mudan
    Tan, Yexiong
    Gonzalez, Frank J.
    Cao, Guangwen
    Wu, Mengchao
    Wen, Hao
    Wu, Tangchun
    Jin, Li
    Chen, Lei
    Wang, Hongyang
    CANCER LETTERS, 2016, 373 (02) : 234 - 240
  • [40] The 70-gene signature test as a prognostic and predictive biomarker in patients with invasive lobular breast cancer
    Jenkins, J. Asher
    Marmor, Schelomo
    Hui, Jane Yuet Ching
    Beckwith, Heather
    Blaes, Anne H.
    Potter, David
    Tuttle, Todd M.
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 191 (02) : 401 - 407
12345